Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
- Status
- COMPLETED
- Phase
- NA
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
- Status
- COMPLETED
- Phase
- PHASE3
PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
- Status
- COMPLETED
- Phase
- PHASE3
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE3
Pyroxamide in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2